Literature DB >> 781653

A double-blind study of tri-potassium di-citrato bismuthate in doudenal ulcer.

D R Shreeve.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 781653

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

Review 1.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

Review 2.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

Review 3.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

4.  Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

5.  Medical treatment of gastric and duodenal ulcer.

Authors:  J H Baron
Journal:  Klin Wochenschr       Date:  1976-10-01

6.  Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.

Authors:  S C Glover; J S Cantlay; J Weir; N A Mowat
Journal:  Dig Dis Sci       Date:  1983-01       Impact factor: 3.199
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.